claim: a standard in-cell elisa assay allows rapid and automated quantification of sars-cov-2 to analyze neutralizing antibodies and antiviral compounds
evidence_1: to replace microscopic counting-based sars-cov-2 prnts by a novel assay exempt from genetically modified viruses, which are inapplicable in most diagnostics departments, we established a simple, rapid, and automated sars-cov-2 neutralization assay employing an in- cell elisa (icelisa) approach.", "a novel in-cell elisa assay allows rapid and automated quantification of sars-cov-2 to analyse neutralizing antibodies and antiviral compounds.", "altogether, the sars-cov-2 icelisa test allows rapid (<48 h in total, read-out in seconds) and automated quantification of virus infection in cell culture to evaluate the efficacy of nabs and antiviral drugs using reagents and equipment present in most routine diagnostics departments."
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )